Osteoporosis
Telomerized presenescent osteoblasts are able to correct bone loss
Published in Women's Health Weekly, July 22nd, 2004
K. Yudoh and associates at St. Marianna University, Japan, wrote, "Previously, we showed that human osteoblasts expressing the human telomerase reverse transcriptase (hTERT) gene exhibited specific survival advantages - the result of breaching the replicative senescence barrier and maintaining the phenotypic and functional properties of primary osteoblasts in vitro over the total replicative capacity of primary osteoblasts."
In that study the researchers "postulated that rejuvenated osteoblasts may have a potential to correct bone loss or osteopenia in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Assisted Reproduction
E.U. enlargement could lead to 'fertility tourism' from West to East - Disease Associations
In young women, depression doubles risk of metabolic syndrome - Gynecologic Surgery
Surgical procedure prevents genital prolapse following Burch colposuspension - Immunology
Inflammation due to CD40 activation in early pregnancy causes fetal resorption - Ovarian Cancer
Lysophospholipid levels are potential disease indicator - Alzheimer Disease
Genistein may be an alternative to estrogen for treatment of AD - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
